{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:48:55Z","timestamp":1779893335349,"version":"3.53.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["igiejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iGIE"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.igie.2025.03.012","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T20:08:02Z","timestamp":1743970082000},"page":"120-128.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Durable insulin elimination after duodenal re-cellularization via electroporation therapy combined with glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes"],"prefix":"10.1016","volume":"4","author":[{"given":"Celine B.E.","family":"Busch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"van den Hoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1351-0267","authenticated-orcid":false,"given":"Annieke C.G.","family":"van Baar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Meiring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Bouwmeester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits","family":"Holleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Nieuwdorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques J.G.H.M.","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.igie.2025.03.012_bib1","series-title":"IDF diabetes atlas","year":"2021"},{"key":"10.1016\/j.igie.2025.03.012_bib2","article-title":"Glycemic control for type 2 diabetes mellitus patients: a systematic review","volume":"14","author":"Bin Rakhis","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.igie.2025.03.012_bib3","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s42255-021-00458-9","article-title":"Diet-induced alteration of intestinal stem cell function underlies obesity and prediabetes in mice","volume":"3","author":"Aliluev","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.igie.2025.03.012_bib4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.peptides.2017.12.010","article-title":"Intestinal peptide changes after bariatric and minimally invasive surgery: relation to diabetes remission","volume":"100","author":"Castagneto","year":"2018","journal-title":"Peptides"},{"key":"10.1016\/j.igie.2025.03.012_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/nutrit\/nuy064","article-title":"Intestinal plasticity in response to nutrition and gastrointestinal surgery","volume":"77","author":"Le Gall","year":"2019","journal-title":"Nutr Rev"},{"key":"10.1016\/j.igie.2025.03.012_bib6","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/01.sla.0000224726.61448.1b","article-title":"The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes","volume":"244","author":"Rubino","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.igie.2025.03.012_bib7","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jpeds.2015.08.020","article-title":"Insulin sensitivity and beta-cell function improve after gastric bypass in severely obese adolescents","volume":"167","author":"Inge","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.igie.2025.03.012_bib8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1053\/j.gastro.2018.02.010","article-title":"The duodenum harbors a broad untapped therapeutic potential","volume":"154","author":"van Baar","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.igie.2025.03.012_bib9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/gutjnl-2020-323608","article-title":"Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial","volume":"71","author":"Mingrone","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.igie.2025.03.012_bib10","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.2337\/dc16-0383","article-title":"Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes: 6-month interim analysis from the first-in-human proof-of-concept study","volume":"39","author":"Rajagopalan","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.igie.2025.03.012_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109194","article-title":"Durable metabolic improvements 2 years after duodenal mucosal resurfacing (DMR) in patients with type 2 diabetes (REVITA-1 study)","volume":"184","author":"van Baar","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.igie.2025.03.012_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/gutjnl-2019-318349","article-title":"Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study","volume":"69","author":"van Baar","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.igie.2025.03.012_bib13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.gie.2024.01.031","article-title":"Insulin sensitivity and beta cell function after duodenal mucosal resurfacing: an open-label, mechanistic, pilot study","volume":"100","author":"Busch","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.igie.2025.03.012_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.gie.2020.12.021","article-title":"Duodenal mucosal resurfacing combined with glucagon-like peptide-1 receptor agonism to discontinue insulin in type 2 diabetes: a feasibility study","volume":"94","author":"van Baar","year":"2021","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.igie.2025.03.012_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjnph-2024-001006","article-title":"Long-term effects of duodenal mucosal resurfacing and liraglutide on glycaemic control in patients with type 2 diabetes","volume":"8","author":"Busch","year":"2025","journal-title":"BMJ Nutr Prev Health"},{"key":"10.1016\/j.igie.2025.03.012_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12933-022-01628-z","article-title":"Eliminating exogenous insulin therapy in patients with type 2 diabetes by duodenal ablation and GLP-1RA decreases risk scores for cardiovascular events","volume":"21","author":"Meiring","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.igie.2025.03.012_bib17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1148\/radiol.2020192190","article-title":"High-voltage electrical pulses in oncology: irreversible electroporation, electrochemotherapy, gene electrotransfer, electrofusion, and electroimmunotherapy","volume":"295","author":"Geboers","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.igie.2025.03.012_bib18","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.gie.2024.04.2904","article-title":"Recellularization via electroporation therapy of the duodenum combined with glucagon-like peptide-1 receptor agonist to replace insulin therapy in patients with type 2 diabetes: 12-month results of a first-in-human study","volume":"100","author":"Busch","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.igie.2025.03.012_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10877-012-9375-8","article-title":"Noninvasive continuous hemodynamic monitoring","volume":"26","author":"Truijen","year":"2012","journal-title":"J Clin Monit Comput"},{"key":"10.1016\/j.igie.2025.03.012_bib24","series-title":"Handbook of psychology and diabetes: a guide to psychological measurement in diabetes research and practice","article-title":"The Diabetes Treatment Satisfaction Questionnaire (DTSQ)","year":"1994"},{"key":"10.1016\/j.igie.2025.03.012_bib25","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2337\/diacare.22.3.530","article-title":"Diabetes treatment satisfaction questionnaire. Change version for use alongside status version provides appropriate solution where ceiling effects occur","volume":"22","author":"Bradley","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.igie.2025.03.012_bib26","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.igie.2025.03.012_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/519080","article-title":"Nexfin noninvasive continuous hemodynamic monitoring: validation against continuous pulse contour and intermittent transpulmonary thermodilution derived cardiac output in critically ill patients","volume":"2013","author":"Ameloot","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.igie.2025.03.012_bib28","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/01.hjh.0000125439.28861.ed","article-title":"Time-domain cross-correlation baroreflex sensitivity: performance on the EUROBAVAR data set","volume":"22","author":"Westerhof","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.igie.2025.03.012_bib29","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fpubh.2017.00258","article-title":"An overview of heart rate variability metrics and norms","volume":"5","author":"Shaffer","year":"2017","journal-title":"Front Public Health"}],"container-title":["iGIE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949708625000391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949708625000391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:02:51Z","timestamp":1762650171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949708625000391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2949708625000391"],"URL":"https:\/\/doi.org\/10.1016\/j.igie.2025.03.012","relation":{},"ISSN":["2949-7086"],"issn-type":[{"value":"2949-7086","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Durable insulin elimination after duodenal re-cellularization via electroporation therapy combined with glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"iGIE","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.igie.2025.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Gastrointestinal Endoscopy.","name":"copyright","label":"Copyright"}]}}